Clostridium botulinum Type B Toxoid Neogen®Vet BotVax® B is a USDA-approved vaccine for the prevention of equine botulism Type B due to Clostridium botulinum in healthy horses.

Clostridium botulinum Type B

• Accounts for more than 85% of equine botulism cases.¹
• Strikes both foals and adult horses.
• Symptoms can progress quickly and are usually rapidly fatal.
• Its spores remain viable in the soil for years.

Risk Factors

• Any baled hay (round, square, big or small), haylage, or silage products.
• Horses or foals that reside in or travel to endemic areas.
• Horses that travel for shows, races, and other equine events.
• Horses that may sustain a wound, including injection site abscesses, umbilical infections, puncture wounds, and castration sites.

Prevention is your best defense!

• Horses are extremely sensitive to botulinum toxins.
• Timely treatment is critical due to botulism’s rapid and severe progression.
• Vaccination is far less expensive than treatment, which can exceed $10,000 with no guarantee of survival.

Storage

• Store unopened vials at 2°-8°C (35°-46°F). DO NOT FREEZE. Use entire contents of the container when first opened. Do not store opened vials.

Warning: Transitory local reactions at the injection site such as heat and minor swelling may occur. Anaphylactoid reactions may occur. Epinephrine is antidotal.

The recommended use and additional information was provided by Neogen. Please click on the link below for more information: https://www.neogen.com/categories/animal-health/clostridium-botulinum-type-b-toxoid-neogenvet-botvax-b/?min=AS_SL_200180